These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33411676)

  • 1. Estimation of the Social Costs of Illegal Drug Use in Poland Using Standardized Methodology.
    Mielecka-Kubie ZJ
    J Ment Health Policy Econ; 2020 Sep; 23(3):139-149. PubMed ID: 33411676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Societal costs of illegal drug use in Sweden.
    Hofmarcher T; Leppänen A; Månsdotter A; Strandberg J; Håkansson A
    Int J Drug Policy; 2024 Jan; 123():104259. PubMed ID: 38035447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of schizophrenia in England.
    Mangalore R; Knapp M
    J Ment Health Policy Econ; 2007 Mar; 10(1):23-41. PubMed ID: 17417045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of drug dependency. Social costs incurred by drug users at intake to the National Treatment Outcome Research Study.
    Healey A; Knapp M; Astin J; Gossop M; Marsden J; Stewart D; Lehmann P; Godfrey C
    Br J Psychiatry; 1998 Aug; 173():160-5. PubMed ID: 9850229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The social cost of illegal drug consumption in Spain.
    García-Altés A; Ollé JM; Antoñanzas F; Colom J
    Addiction; 2002 Sep; 97(9):1145-53. PubMed ID: 12199830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs of diabetes and its complications in Poland.
    Leśniowska J; Schubert A; Wojna M; Skrzekowska-Baran I; Fedyna M
    Eur J Health Econ; 2014 Jul; 15(6):653-60. PubMed ID: 23820625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An estimation of the social cost of illicit drug consumption in Catalonia.
    Vella V; Ibáñez N; Segura L; Colom J; García-Altés A
    Adicciones; 2022 Feb; 34(1):73-82. PubMed ID: 32677701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic consequences of legal and illegal drugs: The case of social costs in Belgium.
    Lievens D; Vander Laenen F; Verhaeghe N; Putman K; Pauwels L; Hardyns W; Annemans L
    Int J Drug Policy; 2017 Jun; 44():50-57. PubMed ID: 28445835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public spending for illegal drug and alcohol treatment in hospitals: an EU cross-country comparison.
    Lievens D; Vander Laenen F; Christiaens J
    Subst Abuse Treat Prev Policy; 2014 Jun; 9():26. PubMed ID: 24981850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The social cost of illicit drugs use in Spain.
    Rivera B; Casal B; Currais L
    Int J Drug Policy; 2017 Jun; 44():92-104. PubMed ID: 28475905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impacts of the COVID-19 pandemic on indirect costs of mental illness and behavioral disorders in Poland.
    Sobczyk K; Holecki T; Rogalska A
    Front Public Health; 2023; 11():1207389. PubMed ID: 37790719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Direct and Indirect Costs of Breast Cancer in Poland: Estimates for 2017-2019.
    Seweryn M; Banas T; Augustynska J; Lorenc O; Kopel J; Pluta E; Skora T
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic and social cost of epilepsy in Poland: 5-year analysis.
    Jędrzejczak J; Majkowska-Zwolińska B; Chudzicka-Bator A; Żerda I; Władysiuk M; Godman B
    Eur J Health Econ; 2021 Apr; 22(3):485-497. PubMed ID: 33582892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The costs of alcohol, illegal drugs, and tobacco in Canada, 2002.
    Rehm J; Gnam W; Popova S; Baliunas D; Brochu S; Fischer B; Patra J; Sarnocinska-Hart A; Taylor B
    J Stud Alcohol Drugs; 2007 Nov; 68(6):886-95. PubMed ID: 17960307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Productivity losses and public finance burden attributable to breast cancer in Poland, 2010-2014.
    Łyszczarz B; Nojszewska E
    BMC Cancer; 2017 Oct; 17(1):676. PubMed ID: 29017454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the burden of diabetes in Poland].
    Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare and wider societal implications of stillbirth: a population-based cost-of-illness study.
    Campbell HE; Kurinczuk JJ; Heazell A; Leal J; Rivero-Arias O
    BJOG; 2018 Jan; 125(2):108-117. PubMed ID: 29034559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect costs and public finance consequences of heart failure in Poland, 2012-2015.
    Łyszczarz B
    BMC Public Health; 2018 Sep; 18(1):1130. PubMed ID: 30231932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.